The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 14, 2016
Filed:
Dec. 17, 2012
Applicant:
Galderma Research & Development, Biot, FR;
Inventors:
Philippe Martel, Biot, FR;
Itaru Suzuki, Shizuoka, JP;
Johannes Voegel, Châteauneuf de Grasse, FR;
Philippe Andres, Peymeinade, FR;
Sandrine Rethore, Valbonne, FR;
Assignee:
GALDERMA RESEARCH & DEVELOPMENT, Biot, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/34 (2006.01); C07K 14/68 (2006.01); A61K 31/216 (2006.01); A61K 45/06 (2006.01); A61K 31/165 (2006.01); A61K 31/192 (2006.01); A61K 31/4178 (2006.01); A61K 31/454 (2006.01); A61K 38/33 (2006.01); A61K 38/35 (2006.01);
U.S. Cl.
CPC ...
A61K 31/216 (2013.01); A61K 31/165 (2013.01); A61K 31/192 (2013.01); A61K 31/4178 (2013.01); A61K 31/454 (2013.01); A61K 38/33 (2013.01); A61K 38/34 (2013.01); A61K 38/35 (2013.01); A61K 45/06 (2013.01);
Abstract
A combination of compounds is described for the treatment and/or prevention of skin conditions linked to hypopigmentation. Also described, is a combination product that includes at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment and/or prevention of skin conditions linked to hypopigmentation, such as vitiligo.